C-T13Kepigenetic clocks, biomarker testing, longevity evidence
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Validate longevity-related claims using curated evidence and biological age testing context.
Digital claims-validation tool associated with MyAgingTests curated longevity research evidence.
Listed in the supplied site analysis as a MyAgingTests tool for claims validation.
Assess pace of aging for biological age reports and longitudinal longevity tracking.
DNA methylation-based pace-of-aging biomarker included in MyAgingTests testing and research evidence materials.
MyAgingTests lists DunedinPACE among its at-home epigenetic biological age tests; supplied research evidence includes a 2023 item titled Caloric restriction slows DunedinPACE.
The supplied material states that caloric restriction slows DunedinPACE, but provides no abstract or numeric result.
Estimate biological age and aging-related risk using an epigenetic clock included in MyAgingTests reports.
DNA methylation-based epigenetic clock assay.
Listed by MyAgingTests as an at-home biological age test component and supported by a 2019 GrimAge publication.
The supplied material identifies GrimAge as a published epigenetic aging clock used by the platform.
Curate evidence on longevity interventions and biological age biomarkers for users, clinicians, and researchers.
Research hub compiling publications and intervention evidence relevant to epigenetic clocks and longevity interventions.
The supplied material lists evidence items on GrimAge, semaglutide and PhenoAge acceleration, caloric restriction and DunedinPACE, and metformin lifespan effects.
Listed evidence includes GrimAge publication support, semaglutide reducing PhenoAge acceleration, caloric restriction slowing DunedinPACE, and metformin extending lifespan 5.8%.
Provide at-home biological age testing and longitudinal tracking for individuals, clinicians, and research cohorts.
DNA methylation-based epigenetic biological age assays with reports incorporating GrimAge, PhenoAge, and DunedinPACE measures.
Testing is described as available through MyAgingTests and powered by Clock Foundation for clinical, research cohort, and longitudinal tracking use cases.
Measure biological age acceleration as part of MyAgingTests biological age reporting and intervention tracking.
Epigenetic biological age clock used in reports and cited in longevity-intervention evidence.
MyAgingTests lists PhenoAge among its at-home epigenetic biological age tests; supplied research evidence includes a 2025 item titled Semaglutide reduces PhenoAge acceleration.
The supplied material states that semaglutide reduces PhenoAge acceleration, but provides no abstract or numeric result.
Analyze longevity protocols against biological age testing and evidence-backed intervention context.
Digital protocol analysis tool associated with MyAgingTests biological age reports and curated longevity evidence.
Listed in the supplied site analysis as a MyAgingTests tool for protocol analysis.